TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clinical response (fistula closure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol-related problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of Patients Who Complete the mPATH-CRC Program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Primary outcome measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of pulmonary hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: amount of tracheal secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FACIT-F Fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: World Health Organization Disability Assessment Schedule 2.0
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Veterans RAND 36-Item
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average Time From HBO Chamber Exit to SRS beam-on
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: local eye symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of HPV types
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Severity of rosacea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Physical function - Gait pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of breath biopsy to discriminate between individuals with and without cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Failed first appropriate shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual Analog Scale pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measured function (6 minute walk, 360 deg turn, walking speed and timed chair stands, 10 lb lift)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dead space variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation of amygdala and cortico-amydalar connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of scores on Hamilton Depression Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Change From Baseline in Monthly Average Number of Headache Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average cytokines plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of coughing episodes during the bronchoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of cough during the bronchoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Endotracheal sedations required to conduct the bronchoscopy
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Heart Failure Participants Deceased at 24 Months
Endpoint domain: Mortality/survival
Primary endpoint: Back Pain Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: recurrence of atrial arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6-Hour Plasma Triglyceride Area Under the Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knee related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of nosocomial bacteremia
Endpoint domain: Adverse events/effects
Primary endpoint: Level of pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-flare of arthritis activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycemic Medication adherence rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of useful TEP exams
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Facility Acquired Pressure Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: CGI scale for borderline personality disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total ROM Worse Hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatty acids associated with obesity and diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bohr's dead space (VDBohr/VT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Modified AX-CPT (d')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fatty Acid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: UDCA levels in vitreous samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin Sensitivity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Global autonomy and risk of falls
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Richmond Agitation-Sedation Scale (RASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adhesion of device underwater
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants Who Experienced at Least One Qualifying Cardiovascular Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Blood Volume (BV) According to Degree of Lesions Differentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Flow (BF) According to Degree of Lesions Differentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Permeability Surface (PS) According to Degree of Lesions Differentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Condom use
Endpoint domain: Adverse events/effects
Primary endpoint: Sex under the influence of alcohol and drugs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of sex partners
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Complete Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Limits of agreement for left ventricular stroke volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean total number of cytokine producing BKV-specific NK and T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: caloric compensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Worst Pain in 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAITRite gait analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surface electromyography (EMG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration of Percent of Injected Dose in the Whole Brain (Cmax, %ID Brain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration of Brain Standardized Uptake Value (Cmax, SUV Brain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of Maximum Radioactivity Concentration in the Brain (Tmax, Brain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain to Plasma Partition Coefficient (Kp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vasoconstriction Potential (Skin Blanching Effect)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Modified Manchester Scar Scale (MMSS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Balance Evaluation System Test (Mini-BESTest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the mDNA/nDNA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: partial remission (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to Train-of-four (TOF) ratio of 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in UPDRS Motor Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Assessment Questionnaire Disability Index (HAQ-DI) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain scores on visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal size calibration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rate of glucose disappearance (Rd)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fMRI Mean BOLD Response in the Amygdalae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Dose-limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Treatment-related Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Tear protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache Days with Moderate or Severe Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: renin-angiotensin-aldosterone activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of patients with complete response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in target behaviour: zinc use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in target behaviour: correct ORS preparation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in target behaviour: Exclusive breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in target behaviour: Handwashing with soap
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of lymph nodes dissected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants diagnosed with lymph node metastasis by <Sup>18<Sup>F-FDG PET/CT dynamic scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants diagnosed with lymph node metastasis by Postoperative pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood pressure accuracy and precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac output accuracy and precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrent ischemic stroke and/or death
Endpoint domain: Mortality/survival
Primary endpoint: Number of Visits To The Emergency Room
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Health functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Inflammation, measured by levels of IL-1, IL-6, and tumor necrosis factor (TNF)-alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time 0 Extrapolated to Infinite Time (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Survival Rate at Day 100
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of intraoperative epileptic seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Total Hydromorphone Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Re-pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants With Japanese Encephalitis Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Yield-in-use tar per cigarette
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Yield-in-use nicotine per cigarette
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of total deaths
Endpoint domain: Mortality/survival
Primary endpoint: Change in Motivation to Stop Smoking Scale (MTSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in motivation to quit
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Molecular fingerprint of primary Wilms tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Protein fingerprint from urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Upper extremity Fugl-Meyer Assessment scale (UE-FM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allogeneic transfusions of red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: reduction of dentin hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fold Change in Expression Profile of Genes and/or Proteins for Arm A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fold Change in Expression Profile of Genes and/or Proteins for Arm B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fold Change in Expression Profile of Genes and/or Proteins for Arm C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in the number of condomless anal sex acts
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Incidence, severity and duration of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Total Score of RSI Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with CABG planning based on MSCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of graft/anastomoses with stenosis or occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time Weighted Average Pain Score in Numerical Rating Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Postoperative Opioid Consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Yale-Brown Obsessive Compulsive Scale Modified for PG (YBOCS-PG)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: bladder-filling sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Clinical Seizure Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Dystonia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Duration of Leuprorelin Exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Duration of Each Leuprorelin Cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Number of Leuprorelin Cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 Hour SPID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication changes
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Alive and Disease Free at Year 2
Endpoint domain: Mortality/survival
Primary endpoint: Characterization of prostate tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: induction to abortion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patient with complete abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with treatment related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: LDL-C change rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Creatinine kinase (CK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Creatinine kinase-MB (CK-MB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: control of focal epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: decrease incidence of drug adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Participation in colorectal cancer screening program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Remission defined as a decrease in Mayo score to ≤ 2 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of ultrasound and FAST scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speed of ultrasound and FAST scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Control Rate (DCR) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Nonpalpable Hardware
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adherence to Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Combined mortality
Endpoint domain: Mortality/survival
Primary endpoint: Post operative pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Survival abstinence rate
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline NRS pain scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of technically successful retrograde CTO-PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Monocyte Inflammatory Protein Nuclear Factor Kappa-B (NFkappaB) (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average nausea rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-Xa activity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Four-week Continuous Abstinence From Cigarette Smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients achieving R0 resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: bleeding during surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Heart rate variation (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Tooth Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of ICU bed days spared
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of Participants Achieving a Target of ≥ 6*10^6 CD34+ Cells/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Need for conversion to hysterectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum Inhibin B Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change From Baseline in Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: subjective appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: short term food intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients with Complete Septum Correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of patients who had an intra-operative Uterine perforation
Endpoint domain: Adverse events/effects
Primary endpoint: degree of colon cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Smoke cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of remnant lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis rate of SSA/P in the remnant tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incomplete resection rate of SSA/P
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Subjects With Treatment-related Serious Adverse Events (SAEs) and Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Response Rate (Confirmed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes